Business Wire

Kymeta and e3 Systems Reveal First Superyacht Sea Trials with Motor Yacht Prior to Monaco Yacht Show

Jaa

Redmond, Washington-based Kymeta, and exclusive superyacht distribution partner, e3 Systems, today revealed that the White Rose of Drachs has been performing the first-ever motor yacht sea trials with Kymeta communications solutions over the last several months with successful results. Up-close views of the trial installation of Kymeta KyWay™ terminals on the yacht will be available at the Monaco Yacht Show September 27-30, 2017.

Kymeta and e3 Systems worked with the owner, captain, and IT manager of the White Rose to perform the months-long sea trial, and outfitted the yacht with four Kymeta KyWay terminals. The terminals were tested with various MIR/CIR services from leading maritime satellite service providers, including Speedcast, which provided service in the Mediterranean. Upon completion of sea trials and commercial release of yacht solutions, Kymeta terminals will be bundled with Kymeta’s KĀLO™ internet access services - powered by the IntelsatOne Flex for Maritime service. The terminals can also be outfitted with MIR/CIR services from service providers like Speedcast.

“We trialed multiple terminal configurations, ranging from single panel solutions to multiple panel solutions. We experienced a few practical installation issues, many of which already have been addressed by Kymeta, and we also realized that the network systems on yachts need to be designed and configured to work in tandem with the improved throughput that Kymeta solutions provide,” said Roger Horner, Managing Director at e3 Systems. “The flat panel beam steering of the antenna and its performance has been fantastic, and we are pleased that the issues found and communicated are already being addressed. Identifying and solving issues is what sea trialing is all about.”

The trials presented Kymeta and e3 engineers with the opportunity to identify and replace various components – both hardware and software. As a software defined antenna technology, Kymeta KyWay terminals used at the trial were given improved and added functionality, remotely, which has never been possible before with traditional mechanically steered antennas.

“The months-long sea trials with the White Rose have provided our engineering team with valuable insights for maritime installations. While we experienced some challenges during the trials, it wasn’t anything we couldn’t overcome, and it is now clear that domeless vessels are a new reality for the yacht industry,” said Håkan Olsson, Vice President of Maritime at Kymeta. “This is a major milestone for the maritime industry, where reliable, flat, lightweight satellite connectivity will open an entirely new world of communication capabilities.”

The trialing period also afforded Andrew Schofield, captain of the White Rose, to witness firsthand the ease with which Kymeta communication solutions can be updated and managed – even while at sea. “One day while testing the Kymeta solutions at sea, the e3 Systems and Kymeta teams removed terminals, changed components, and reinstalled them within minutes,” said Schofield. “With conventional antennas, we would have been in the yard for a few days with a crane to achieve the same results. The quick installation of the Kymeta solution is a big time and money-saver.”

Schofield recognizes other benefits in addition to saved time and manpower. “We have been anticipating Kymeta technology since 2015 when we first saw conceptual animations of the technology,” said Schofield. “We are proud to be the first motor yacht to perform sea trials with Kymeta technology. We look forward to progressing from the current temporary trial installation to the finalized fully-integrated solution, which will rid the yacht of the current VSAT and TVRO domes. This will remove over five tons of weight from her super structure and provide the yacht with permanent access to the internet.”

About Kymeta
What’s the missing link to connecting billions of people to high-speed mobile access? Antennas. And Kymeta offers the world’s only commercially-viable electronically-scanning satellite antennas and terminals. Kymeta antennas and terminals deliver high-throughput communications for land, sea, and air, making mobile connectivity as available as a view of the sky. Plus, the world’s largest satellite operator, Intelsat, has joined forces with Kymeta to deliver KĀLO global access services that combine with Kymeta antennas and terminals to provide revolutionary mobile connectivity. Without Kymeta mTenna™ technology, connecting and staying connected to all those new satellites while on the move will be difficult, if not impossible.

If it moves, Kymeta will keep it connected. Anywhere.

For more information, visit kymetacorp.com and KALO.net.

About e3 Systems
e3 Systems® is a leading communications integrator and solutions provider for the marine industry. The company connects yachts globally through a diverse portfolio of communication systems including its HYBRID solution which synchronises VSAT, Inmarsat, Iridium, 3G, 4G and Wi-Fi.

In addition, e3 provides an extensive suite of services covering cyber security and training, comprehensive IT support, data management through the Advanced Monitoring and Management System e3.ARMMS, and content provision including TV and internet.

e3 operates from the Mediterranean and the USA with thirty partners worldwide. It is part of the marine electronics group grupoarbulu.

Contact information

Business Inquiries for Kymeta:
Kymeta Corporation
Lisa Dreher, +1 425-658-8724
Director of Marketing
ldreher@kymetacorp.com
or
Media Inquiries for Kymeta:
The Summit Group
Amy Oliver, +1 801-990-1185
PR/Content Manager
aoliver@summitslc.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme